Editions   North America | Europe | Magazine


At Pharmapack Paris, Schreiner MediPharm to Showcase New First-Opening Indication Feature for Protective Needle-Trap Solution

Press release from the issuing company

The security seal integrated in the needle protection system reliably indicates first opening of the prefilled syringe.

Novel combination of needlestick and product protection will debut at Hall 7.2, Booth D46.

Blauvelt, NY – Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, will introduce a new first-opening indication for its popular Needle-Trap solution at Pharmapack Paris, February 1-2. At Booth D46 in Hall 7.2, the company will debut a special security seal integrated into Needle-Trap that reliably indicates whether a prefilled syringe has been previously opened, helping protect the integrity of its contents until final use.

Drug packaging integrity is a critical aspect of a secure supply chain for pharmaceutical manufacturers. Regulations such as the EU Falsified Medicines Directive contribute to supply chain security, but generally address only secondary packaging. As a result, primary containers like prefilled syringes require more specific solutions for tamper evidence and first-opening indication.

Due to its integrated plastic trap, the Needle-Trap needle protection label poses special challenges to a first-opening indication feature. In addition to smooth processing in pharmaceutical manufacturing operations, ease of use by healthcare staff also required consideration.

Schreiner MediPharm designed for its Needle-Trap solution a novel closure seal with a tab ending on the syringe cap. Before injection, the needle trap is first folded sideways, as usual. While the cap is being pulled off, a perforation automatically activates the label-integrated seal, which irreversibly indicates the label’s initial opening. Special security cuts prevent undetected removal of the seal. For authenticity verification, overt authentication features such as a guilloche pattern or covert security features can be added.

Needle-Trap’s new feature provides pharmaceutical manufacturers with a multifunctional and cost-efficient solution, combining protection of healthcare staff against needlestick injuries with first-opening indication that ensures unit-level prefilled syringe integrity. Healthcare staff benefit from efficient and reliable needle protection as well as convenient first-opening indication that is irreversible and detectable at first glance, enhancing both product and patient safety. In addition, the new Needle-Trap version can be easily integrated into existing pharmaceutical manufacturing processes.


Join the discussion Sign In or Become a Member, doing so is simple and free

WhatTheyThink is the official show daily media partner of drupa 2024. More info about drupa programs